Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants.
about
Inhaled versus systemic corticosteroids for the treatment of chronic lung disease in ventilated very low birth weight preterm infantsInhaled versus systemic corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonatesSystemic corticosteroid regimens for prevention of bronchopulmonary dysplasia in preterm infantsIntratracheal instillation of corticosteroids using surfactant as a vehicle for the prevention of chronic lung disease in preterm infants with respiratory distress syndromeInhaled versus systemic corticosteroids for the treatment of chronic lung disease in ventilated very low birth weight preterm infantsInhaled versus systemic corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonatesThe Magpie Trial follow up study: outcome after discharge from hospital for women and children recruited to a trial comparing magnesium sulphate with placebo for pre-eclampsia [ISRCTN86938761]Acute neonatal glucocorticoid exposure produces selective and rapid cerebellar neural progenitor cell apoptotic deathEvidence for adverse effect of perinatal glucocorticoid use on the developing brainGlucocorticoid receptor expression in the cortex of the neonatal rat brain with and without focal cerebral ischemiaSystemic corticosteroid regimens for prevention of bronchopulmonary dysplasia in preterm infants.Glucocorticoid-attenuated response genes induced in the lung during endotoxemia.Improved weight attainment of extremely low-gestational-age infants with bronchopulmonary dysplasia.Impact of postnatal corticosteroid use on neurodevelopment at 18 to 22 months' adjusted age: effects of dose, timing, and risk of bronchopulmonary dysplasia in extremely low birth weight infantsNeurodevelopmental outcome of extremely low birth weight infants from the Vermont Oxford network: 1998-2003Oxidative stress in the developing brain: effects of postnatal glucocorticoid therapy and antioxidants in the rat.Follow-up study of a randomized controlled trial of postnatal dexamethasone therapy in very low birth weight infants: effects on pulmonary outcomes at age 8 to 11 yearsPlasma leptin and ghrelin in the neonatal rat: interaction of dexamethasone and hypoxia.Placental 11-beta hydroxysteroid dehydrogenase methylation is associated with newborn growth and a measure of neurobehavioral outcome.A psychoneuroimmunologic examination of cumulative perinatal steroid exposures and preterm infant behavioral follow-up.Cumulative perinatal steroids: child development of preterm infantsAerobic fitness and physical activity levels of children born prematurely following randomization to postnatal dexamethasone.Granulocyte colony stimulating factor attenuates hyperoxia-induced lung injury by down-modulating inflammatory responses in neonatal rats.The changing risk of infant mortality by gestation, plurality, and race: 1989-1991 versus 1999-2001Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine.Antenatal steroid therapy for fetal lung maturation and the subsequent risk of childhood asthma: a longitudinal analysis.Modulation of Lgl1 by steroid, retinoic acid, and vitamin D models complex transcriptional regulation during alveolarization.Glucocorticoid receptor stimulation and the regulation of neonatal cerebellar neural progenitor cell apoptosisTargeting inflammation to prevent bronchopulmonary dysplasia: can new insights be translated into therapies?Nebulized furosemide in the treatment of bronchopulmonary dysplasia in preterm infants.Postnatal corticosteroids for prevention and treatment of chronic lung disease in the preterm newborn.Is retinopathy of prematurity increasing among infants less than 1250 g birth weight?Systemic Hydrocortisone To Prevent Bronchopulmonary Dysplasia in preterm infants (the SToP-BPD study); a multicenter randomized placebo controlled trial.Pulmonary effects of neonatal hydrocortisone treatment in ventilator-dependent preterm infants.Regulation of corticoid and serotonin receptor brain system following early life exposure of glucocorticoids: long term implications for the neurobiology of mood.High Risk Infants Follow-Up: A Case Study in Iran.Long-term Effects of Multiple Glucocorticoid Exposures in Neonatal MiceDifferential effects of cholesterol and budesonide on biophysical properties of clinical surfactant.Respiratory complications of preterm birth.Early-childhood neurodevelopmental outcomes are not improving for infants born at <25 weeks' gestational age
P2860
Q24197845-4CC112E6-B7BC-4159-B991-5771850F5024Q24197850-79D16439-9788-4929-876B-DAF36AB6ED72Q24201323-4000BE1D-7487-4423-A9E8-58A292E859A1Q24235457-8369333F-F212-44B0-A784-71640E2EB4DBQ24243584-3F85383C-3935-49E6-A5FC-466CE2BAA311Q24250182-C80C652B-D1D2-4257-9853-6BDB55A0B6A8Q24563293-48B5E999-DE43-4CDA-BD09-00364C481FCFQ24657730-92E8684A-2741-4619-8F13-57CE88B585E9Q26865030-30265249-8A1D-40DE-B906-EE5DA3108FFBQ28579514-4699731F-0902-463D-87FB-22827020A391Q30238696-EBF9A058-CD31-4E4C-8616-17372AD5E759Q30841886-916A6910-6312-491B-8474-364CCEAD6DEAQ33710305-BD3EFCC4-1E5B-4D9C-AC79-9036653EF8B5Q33758531-964769FB-8934-40F6-A675-434CF136E6A1Q33928084-9462BB15-8AE6-41C4-9A86-EEF7964A2677Q33941213-D399E522-6A1C-4919-A60D-47655C96CE46Q33962521-51C6B24A-4670-49D3-89EB-AF2E6230D257Q34074757-1070BD0F-DD03-4E8A-8746-3D8681459E5EQ34203026-36CFFA94-FAE8-4126-8C8D-A36F6BC67789Q34224396-534924A0-E6B8-4D06-9673-EE917E25ABC6Q34353377-DE95C2DE-E678-4006-B68B-5A50232F6FDDQ34361122-DFBA1130-9580-485D-9350-4F3C51742E77Q34474662-F24DF3E3-4C29-4BC0-8C00-489EBAF8DD1DQ34586693-3335430B-1B50-489D-A83D-EFB8B4254815Q34605888-88683545-B178-416C-B3A4-386C5B8B897AQ34730041-B62DD6D8-F990-492F-8CEE-1F7AB77AB681Q35014998-AEA61B01-2C0D-41B0-8721-2F4C20996A59Q35043097-191C939F-FAC6-4DE0-84DC-76E05FD808B2Q35070866-936B6823-22F7-4DF0-8F81-593D753936B1Q35104985-6F811B28-1555-4A25-B1EC-582A0D007952Q35294711-9A00DB63-4A66-42F4-A059-F3AF046A5AE6Q35597020-696E9EB3-1CD1-4546-BB02-73996C9D6DDFQ35632102-4B6E0D30-2DFA-432F-B53D-F762BACDEF09Q35647128-F5F3A810-11C4-44CF-8BA1-1A718B96CFA4Q35740275-EB77B65C-2EF2-474A-8CAB-DACA16F61866Q35744949-217A9817-87C8-4D0C-A0D1-4E914E99C0FBQ35777852-DD5CFF22-2072-479A-BA97-A3915867D825Q35917662-EF0A6511-038F-4CAA-AE58-CD0E8D33BF06Q35925119-058046DD-5774-4B18-B643-164E580B9C2BQ36032934-E5E60BD5-C21A-437D-8C8C-E08A2B626022
P2860
Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants.
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants.
@ast
Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants.
@en
Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants.
@nl
type
label
Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants.
@ast
Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants.
@en
Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants.
@nl
prefLabel
Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants.
@ast
Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants.
@en
Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants.
@nl
P356
P1433
P1476
Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants.
@en
P2093
Committee on Fetus and Newborn
P304
P356
10.1542/PEDS.109.2.330
P407
P577
2002-02-01T00:00:00Z